Related Experiment Videos
Renal artery clipping attenuates the progression of adriamycin nephropathy
A L Balbi1, R J Franco, P Barretti
1Department of Medicine, Botucatu Medical School (UNESP), São Paulo, Brazil.
Abstract:
This study was designed to analyze the impact of diminished renal perfusion pressure due to renal clipping on the rat model of adriamycin nephropathy. Male Wistar rats, divided into four groups (n = 9 per group) were injected with saline as control (C), adriamycin 3 ml/kg (Ad), saline with the left renal artery clipped (Rv), and adriamycin plus clip (AdRv). After 24 weeks mean arterial pressure (MAP), inulin, and p-aminohippurate (PAH) clearances were performed to evaluate renal function. Morphologic analysis included histologic criteria of percentage of glomerulosclerosis and tubulointerstitial lesion index (TILI). The MAP (mm Hg) was similar between Rv (143+/-13) and AdRv (154+/-20), but higher (P < .05) than C (120 +/-8) and Ad (124+/-11). Inulin clearance (mL/min/ 100 g) in Ad (0.2+/-0.05) was smaller than in C (0.53+/-0.17) and Rv (0.4+/-0.01) (P < .05), and was at an intermediate level in AdRv (0.33+/-0.2). The level of PAH (mL/min/100 g) was normal at 1.76 in C, and diminished more in Ad (0.58) than in Rv (1.06) and AdRv (1.18) (P < .05). Both Ad and the AdRv nonclipped kidneys had the highest degree of glomerulosclerosis (33% and 25%) and TILI (7% and 8%), respectively, compared with C and Rv (both 0%), whereas the clipped kidneys displayed intermediate degrees (9% and 5%) (P < .05 v nonclipped). The data suggest that diminished perfusion pressure of the clipped kidney, by decreasing the intraglomerular pressure, protects the glomerulus from damage and attenuates the evolution of adriamycin nephropathy.
Insights
Reduced kidney blood flow in rats protected glomeruli from adriamycin-induced damage. This suggests lowering renal perfusion pressure may mitigate nephropathy progression.
Area of Science:
- Nephrology
- Renal Physiology
- Experimental Pathology
Background:
- Adriamycin (doxorubicin) is a chemotherapy agent known to cause nephrotoxicity.
- Understanding mechanisms to protect against adriamycin-induced kidney damage is crucial for patient outcomes.
- Renal perfusion pressure is a key factor in kidney function and disease progression.
Purpose of the Study:
- To investigate the impact of diminished renal perfusion pressure on adriamycin-induced nephropathy in a rat model.
- To evaluate the protective effects of reduced renal blood flow on glomerular and tubulointerstitial damage.
Main Methods:
- Male Wistar rats were divided into four groups: control, adriamycin, renal artery clipped (reduced perfusion), and adriamycin with renal artery clipped.
- Renal function was assessed by measuring mean arterial pressure (MAP), inulin, and p-aminohippurate (PAH) clearances over 24 weeks.
- Histological analysis quantified glomerulosclerosis and tubulointerstitial lesion index (TILI).
Main Results:
- Adriamycin administration significantly reduced renal function (inulin and PAH clearance) and increased kidney damage.
- Rats with a clipped renal artery (reduced perfusion pressure) showed significantly less glomerulosclerosis and TILI compared to non-clipped kidneys.
- The adriamycin plus clipped group demonstrated intermediate levels of renal function and damage, suggesting a protective effect of reduced perfusion.
Conclusions:
- Diminished renal perfusion pressure, achieved through renal artery clipping, offers a protective effect against adriamycin-induced nephropathy in rats.
- Lowering intraglomerular pressure by reducing renal perfusion may attenuate glomerular damage and slow disease progression.
- These findings highlight the potential therapeutic role of modulating renal perfusion in managing nephrotoxic kidney injury.